Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug Names Tentatively Accepted As Trademarks Could Be Placed On Website

Executive Summary

FDA may make tentatively accepted tradenames for prescription drugs viewable on the Internet

You may also be interested in...



Drug Names Will Be Reviewed By FDA Within 90 Days Under PDUFA Timetable

FDA is establishing timetables for review of proprietary drug names as part of the next cycle of the Prescription Drug User Fee Act

Drug Names Will Be Reviewed By FDA Within 90 Days Under PDUFA Timetable

FDA is establishing timetables for review of proprietary drug names as part of the next cycle of the Prescription Drug User Fee Act

FDA Drug Name Guidance Is “Premature” Without More Data, Cmte. Says

Development of an FDA guidance on how to screen proprietary drug names for potential medication errors would be premature without more outcomes data, the Drug Safety & Risk Management Advisory Committee agreed Dec. 4

Related Content

UsernamePublicRestriction

Register

PS042078

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel